Fidelity National Information Servcs Inc (FIS) Stock Price Today
Aura AI Summary
Key Stats
- $22.76BMarket Cap
- -Volume
- TechnologySector
- $71.7652W High
- $37.7252W Low
- -Typical Hold Time
- $43.27BEnterprise Value
- 3.99%Div Yield
- -Trading Activity
Track Fidelity National Information Servcs Inc (FIS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Fidelity National Information Servcs Inc has traded between a low of $37.72 and a high of $71.76, highlighting its annual price range. Buy and sell Fidelity National Information Servcs Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Fidelity National Information Servcs Inc
Fidelity National Information Services' legacy operations provide core and payment processing services to banks, but its business has expanded over time. By acquiring Sungard in 2015, the company now provides record-keeping and other services to investment firms. With the acquisition of Worldpay in 2019, FIS now provides payment processing services for merchants and holds leading positions in the United States and United Kingdom. About a fourth of revenue is generated outside North America.
Most Recent News
Major stocks fall sharply amid mixed earnings and negative outlooks, signaling broader market concerns.
Several leading stocks, including SoundThinking, TSS, and ADI Global Distribution, dropped significantly due to factors like lowered revenue forecasts and disappointing quarterly results. SoundThinking fell over 25% after cutting its revenue outlook ...

Definitive Healthcare posts a stellar 41.44% ROIC, far surpassing its 5.78% capital cost.
Definitive Healthcare Corp. stands out with a remarkable Return on Invested Capital (ROIC) of 41.44%, significantly exceeding its Weighted Average Cost of Capital (WACC) of 5.78%. This means the company generates over seven times the value for every ...

Abeona Therapeutics' price target cut to $15 after Q2 revenue miss and operational issues with Zevaskyn therapy.
Industrial Alliance Securities lowered Abeona Therapeutics' price target from $20 to $15 following a 14% stock drop after the company reported Q2 revenues of $11.4 million, missing analyst expectations. The company faces operational challenges with i...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.